PPCB
Propanc Biopharma
$1.32
−$0.05 (−3.65%)Jul 27, 2026
Key metrics
The numbers that frame PPCB today
- Market cap
- $3.01M
- P/E (TTM)
- -0.2
- EV / FCF
- -0.8
- ROIC
- -134%
- Div yield
- 0%
- Debt / equity
- 0.1
Growth
Revenue and earnings trend for PPCB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PPCB
Is Propanc Biopharma a good buy?
No. Propanc Biopharma has poor quality. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Propanc Biopharma is selling at a very high price.
What is the market capitalization of PPCB?
Propanc Biopharma's market capitalization is $3.01M.
What is the P/E ratio for PPCB stock?
Propanc Biopharma's current P/E ratio is -0.2.
Does PPCB stock pay dividends?
Propanc Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PPCB?
Propanc Biopharma's Debt / Equity ratio is 0.06.